Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boxall

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Hospital Infection|May 15, 2012
Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosisA Mutagi, E F Nash, S Cameron, et al.
British Journal of Cancer|May 1, 1993
Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodentsM J McKeage, S E Morgan, F E Boxall, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylatesM J McKeage, S E Morgan, F E Boxall, et al.
Molecular Pharmacology|March 20, 2003
Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)]José M Pérez, Lloyd R Kelland, Eva I Montero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in miceF I Raynaud, F E Boxall, P M Goddard, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis BE M Sokal, E A Roberts, G Mieli-Vergani, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.
Cancer Research|August 1, 1994
Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivoM J McKeage, L R Kelland, F E Boxall, et al.
Gut|July 14, 1999
Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein functionP L Shields, A Owsianka, W F Carman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administrationM J McKeage, P Mistry, J Ward, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Hospital Infection|May 15, 2012
Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosisA Mutagi, E F Nash, S Cameron, et al.
British Journal of Cancer|May 1, 1993
Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodentsM J McKeage, S E Morgan, F E Boxall, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylatesM J McKeage, S E Morgan, F E Boxall, et al.
Molecular Pharmacology|March 20, 2003
Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)]José M Pérez, Lloyd R Kelland, Eva I Montero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in miceF I Raynaud, F E Boxall, P M Goddard, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis BE M Sokal, E A Roberts, G Mieli-Vergani, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.
Cancer Research|August 1, 1994
Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivoM J McKeage, L R Kelland, F E Boxall, et al.
Gut|July 14, 1999
Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein functionP L Shields, A Owsianka, W F Carman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administrationM J McKeage, P Mistry, J Ward, et al.
Pageof 5